跳转至内容
Merck
CN
  • Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma.

Proteomics-based identification of the tumor suppressor role of aminoacylase 1 in hepatocellular carcinoma.

Cancer letters (2014-05-23)
Xuyong Wei, Jie Li, Haiyang Xie, Qi Ling, Jianguo Wang, Di Lu, Lin Zhou, Xiao Xu, Shusen Zheng
摘要

The present work aimed to investigate the expression and role of aminoacylase 1 (ACY1) in hepatocellular carcinoma (HCC) based on a proteomic study. The study results revealed that the expression of ACY1 was much lower in HCC tissues. ACY1 expression significantly correlated with the serum alpha fetoprotein level and tumor invasiveness. The knockdown of ACY1 in SMMC7721 cells promoted cell viability and invasiveness. In contrast, the restoration of ACY1 in BEL7402 cells inhibited cell viability and invasiveness. Further studies indicated that the knockdown of ACY1 increased the protein expression of transforming growth factor beta 1 and extracellular signal-regulated kinase 1 expression. The study's results indicated that ACY1 acts as a tumor suppressor in HCC.

材料
货号
品牌
产品描述

Sigma-Aldrich
L -赖氨酸, ≥98% (TLC)
Sigma-Aldrich
荧光素异硫氰酸酯异构体I, suitable for protein labeling, ≥90% (HPLC), powder
Sigma-Aldrich
荧光素 5(6)-异硫氰酸酯, BioReagent, suitable for fluorescence, mixture of 2 components, ≥90% (HPLC)
Sigma-Aldrich
L -赖氨酸, crystallized, ≥98.0% (NT)
Sigma-Aldrich
荧光素 5(6)-异硫氰酸酯, ≥90% (HPLC)
Sigma-Aldrich
荧光素异硫氰酸酯异构体I, ≥97.5% (HPLC)
Supelco
L -赖氨酸, analytical standard
Sigma-Aldrich
L -赖氨酸, Vetec, reagent grade, ≥98%
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Acy1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Chn1
Sigma-Aldrich
MISSION® esiRNA, targeting human CHN1
Sigma-Aldrich
MISSION® esiRNA, targeting human ACY1, ABHD14A-ACY1